Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself.

[1]  Michele Cilli,et al.  p49, a putative HLA class I‐specific inhibitory NK receptor belonging to the immunoglobulin superfamily , 1998, European journal of immunology.

[2]  D. Goodlett,et al.  HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. , 1998, Journal of immunology.

[3]  M. Llano,et al.  HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  G. Ogg,et al.  Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. , 1998, Journal of immunology.

[5]  J. Bell,et al.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.

[6]  M. Colonna,et al.  A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells , 1997, The Journal of experimental medicine.

[7]  J. Dausset,et al.  Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Fisher,et al.  Identification of a Thymic Epithelial Cell Subset Sharing Expression of the Class Ib HLA-G Molecule with Fetal Trophoblasts , 1997, The Journal of experimental medicine.

[9]  I. Melero,et al.  The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. , 1997, Journal of immunology.

[10]  J. Dausset,et al.  The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. McMichael,et al.  The human major histocompatibility complex class Ib molecule HLA‐E binds signal sequence‐derived peptides with primary anchor residues at positions 2 and 9 , 1997, European journal of immunology.

[12]  H. Rammensee,et al.  Human Histocompatibility Leukocyte Antigen (HLA)-G Molecules Inhibit NKAT3 Expressing Natural Killer Cells , 1997, The Journal of experimental medicine.

[13]  O. Mandelboim,et al.  Protection from Natural Killer Cell-Mediated Lysis by HLA-G Expression on Target Cells , 1996, Science.

[14]  H. Rammensee,et al.  Nonclassical HLA-G molecules are classical peptide presenters , 1996, Current Biology.

[15]  P. A. Biro,et al.  The human amnion is a site of MHC class Ib expression: evidence for the expression of HLA-E and HLA-G. , 1995, Journal of immunology.

[16]  J. Johnson,et al.  The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein. , 1992, Journal of immunology.

[17]  S. Fisher,et al.  A class I antigen, HLA-G, expressed in human trophoblasts. , 1990, Science.

[18]  K. Rock,et al.  Antigen processing and presentation by the class I major histocompatibility complex. , 1996, Annual review of immunology.

[19]  J. Rodgers,et al.  Antigen presentation by major histocompatibility complex class I-B molecules. , 1994, Annual review of immunology.